Alto Neuroscience Currently Up Eight Consecutive Days, On Pace for Longest Winning Streak Since October 2024 -- Data Talk

Dow Jones
Dec 20, 2025

Alto Neuroscience, Inc. ( ANRO ) is currently at $19.48, up $0.03 or 0.15%

 

--Would be highest close since Feb. 5, 2024, when it closed at $21.80

--On pace for largest percent increase since Dec. 18, 2025, when it rose 6.93%

--Currently up 10 of the past 11 days

--Currently up eight consecutive days; up 47.02% over this period

--Longest winning streak since Oct. 16, 2024, when it rose for 10 straight trading days

--Best eight day stretch since the eight days ending Oct. 29, 2025, when it rose 130.92%

--Up 28.75% this week; best weekly performance since the week ending Oct. 31, 2025, when it rose 29.00%

--Up 40.65% month-to-date

--Up 360.52% year-to-date; on pace for best year on record (Based on available data back to Feb. 2, 2024)

--Down 10.64% from its all-time closing high of $21.80 on Feb. 5, 2024

--Up 400.77% from 52 weeks ago (Dec. 20, 2024), when it closed at $3.89

--Would be a new 52-week closing high

--Up 982.22% from its 52-week closing low of $1.80 on April 4, 2025

--Traded as high as $20.91; highest intraday level since Feb. 6, 2024, when it hit $21.64

--Up 7.49% at today's intraday high

 

All data as of 2:52:30 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 19, 2025 14:54 ET (19:54 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10